The table below shows Edwards Lifesciences Corp's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$1.60B
$542.30M
$895.80M
$1.22B
$1.73B
$1.05B
Capital expenditure
$260.20M
$252.40M
$253.00M
$244.60M
$325.80M
$407.00M
Investing cash flow
-$712.90M
$2.31B
$173.80M
$252.30M
-$1.72B
-$531.10M
Dividends paid
-
-
-
-
-
-
EW operating cash flow (10-K history)
Edwards Lifesciences Corp reported operating cash flow of $1.60B for fiscal year 2025. That is up 194.2% from $542.30M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $704.40M (FY 2016) to $1.60B. Figures come from the company's audited annual reports as filed with the SEC.
